Stopped early
Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women
NCT01866917 · Montefiore Medical Center · Updated 20 Aug 2020
- What is being tested
- Ropivacaine 0.5% 20cc injectate bilaterally; Placebo
- For
- Pain
- Kind of study
- Tests a treatment or device on volunteers. Phase 1 and Phase 2.
- Who can join
- Ages 18 years and older. About 35 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started April 2013, ends April 2016. Registered 3 June 2013.
- Results
- Posted on the registry on 20 Aug 2020.
In the researchers' words
Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.
Sites
- Moses Medical CenterThe Bronx, New York, United States